{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T10:36:18Z","timestamp":1771583778493,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2408085J046"],"award-info":[{"award-number":["2408085J046"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471819"],"award-info":[{"award-number":["82471819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10067-026-07963-w","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T02:11:10Z","timestamp":1769393470000},"page":"1709-1720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PP2A dysfunction mediated by PPP2R1A deficiency drives cGAS\u2013STING-dependent hyperinflammation in SLE CD14+ monocytes"],"prefix":"10.1007","volume":"45","author":[{"given":"Xuan","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0828-1583","authenticated-orcid":false,"given":"Zhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"7","key":"7963_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4(7):499\u2013511","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"7963_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.59.4.283","volume":"59","author":"F Steinbach","year":"2000","unstructured":"Steinbach F, Henke F, Krause B, Thiele B, Burmester GR, Hiepe F (2000) Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann Rheum Dis 59(4):283\u2013288","journal-title":"Ann Rheum Dis"},{"issue":"26","key":"7963_CR3","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","volume":"117","author":"C Jing","year":"2020","unstructured":"Jing C, Castro-Dopico T, Richoz N, Tuong ZK, Ferdinand JR, Lok LSC, Loudon KW, Banham GD, Mathews RJ, Cader Z et al (2020) Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proc Natl Acad Sci U S A 117(26):15160\u201315171","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"7963_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.autrev.2007.01.017","volume":"6","author":"M Kavai","year":"2007","unstructured":"Kavai M, Szegedi G (2007) Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus. Autoimmun Rev 6(7):497\u2013502","journal-title":"Autoimmun Rev"},{"issue":"7","key":"7963_CR5","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1038\/s41380-021-01065-6","volume":"26","author":"A Tripathi","year":"2021","unstructured":"Tripathi A, Whitehead C, Surrao K, Pillai A, Madeshiya A, Li Y, Khodadadi H, Ahmed AO, Turecki G, Baban B et al (2021) Type 1 interferon mediates chronic stress-induced neuroinflammation and behavioral deficits via complement component 3-dependent pathway. Mol Psychiatry 26(7):3043\u20133059","journal-title":"Mol Psychiatry"},{"issue":"12","key":"7963_CR6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri3921","volume":"15","author":"GN Barber","year":"2015","unstructured":"Barber GN (2015) STING: infection, inflammation and cancer. Nat Rev Immunol 15(12):760\u2013770","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"7963_CR7","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/annrheumdis-2018-212988","volume":"77","author":"Y Kato","year":"2018","unstructured":"Kato Y, Park J, Takamatsu H, Konaka H, Aoki W, Aburaya S, Ueda M, Nishide M, Koyama S, Hayama Y et al (2018) Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus. Ann Rheum Dis 77(10):1507\u20131515","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"7963_CR8","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1111\/febs.14617","volume":"285","author":"J Westermarck","year":"2018","unstructured":"Westermarck J (2018) Targeted therapies don\u2019t work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back. FEBS J 285(22):4139\u20134145","journal-title":"FEBS J"},{"issue":"1","key":"7963_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbamcr.2018.07.010","volume":"1866","author":"S Reynhout","year":"2019","unstructured":"Reynhout S, Janssens V (2019) Physiologic functions of PP2A: lessons from genetically modified mice. Biochim Biophys Acta Mol Cell Res 1866(1):31\u201350","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"4","key":"7963_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2014.01.015","volume":"40","author":"L Long","year":"2014","unstructured":"Long L, Deng Y, Yao F, Guan D, Feng Y, Jiang H, Li X, Hu P, Lu X, Wang H et al (2014) Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling. Immunity 40(4):515\u2013529","journal-title":"Immunity"},{"key":"7963_CR11","doi-asserted-by":"crossref","unstructured":"Ho WS, Mondal I, Xu B, Das O, Sun R, Chiou P, Cai X, Tahmasebinia F, McFadden E, Wu CY et al (2023) PP2Ac\/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages. J Clin Invest 133(6)\uff1ae162139","DOI":"10.1172\/JCI162139"},{"key":"7963_CR12","volume":"12","author":"L Lv","year":"2021","unstructured":"Lv L, Qin T, Huang Q, Jiang H, Chen F, Long F, Ren L, Liu J, Xie Y, Zeng M (2021) Targeting tristetraprolin expression or functional activity regulates inflammatory response induced by MSU crystals. Front Immunol 12:675534","journal-title":"Front Immunol"},{"issue":"8","key":"7963_CR13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.61.8.718","volume":"61","author":"F Buttgereit","year":"2002","unstructured":"Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, Kirwan J, K\u00f6hler L, Van Riel P, Vischer T et al (2002) Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61(8):718\u2013722","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"7963_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050155","volume":"5","author":"H Hombauer","year":"2007","unstructured":"Hombauer H, Weismann D, Mudrak I, Stanzel C, Fellner T, Lackner DH, Ogris E (2007) Generation of active protein phosphatase 2A is coupled to holoenzyme assembly. PLoS Biol 5(6):e155","journal-title":"PLoS Biol"},{"issue":"5074","key":"7963_CR15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1325671","volume":"257","author":"J Chen","year":"1992","unstructured":"Chen J, Martin BL, Brautigan DL (1992) Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 257(5074):1261\u20131264","journal-title":"Science"},{"issue":"6","key":"7963_CR16","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1073\/pnas.90.6.2500","volume":"90","author":"H Guo","year":"1993","unstructured":"Guo H, Damuni Z (1993) Autophosphorylation-activated protein kinase phosphorylates and inactivates protein phosphatase 2A. Proc Natl Acad Sci U S A 90(6):2500\u20132504","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"7963_CR17","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V et al (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100(5):2610\u20132615","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"7963_CR18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","volume":"197","author":"L Bennett","year":"2003","unstructured":"Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197(6):711\u2013723","journal-title":"J Exp Med"},{"issue":"6","key":"7963_CR19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2006.09.014","volume":"18","author":"V Pascual","year":"2006","unstructured":"Pascual V, Farkas L, Banchereau J (2006) Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol 18(6):676\u2013682","journal-title":"Curr Opin Immunol"},{"key":"7963_CR20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.905109","volume":"13","author":"H Wobma","year":"2022","unstructured":"Wobma H, Shin DS, Chou J, Dedeo\u011flu F (2022) Dysregulation of the cGAS-STING pathway in monogenic autoinflammation and lupus. Front Immunol 13:905109","journal-title":"Front Immunol"},{"issue":"12","key":"7963_CR21","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow MK (2014) Type I interferon in the pathogenesis of lupus. J Immunol 192(12):5459\u20135468","journal-title":"J Immunol"},{"issue":"2","key":"7963_CR22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4049\/jimmunol.166.2.966","volume":"166","author":"TP Shanley","year":"2001","unstructured":"Shanley TP, Vasi N, Denenberg A, Wong HR (2001) The serine\/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling. J Immunol 166(2):966\u2013972","journal-title":"J Immunol"},{"key":"7963_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010818-021358","volume":"59","author":"J Chun","year":"2019","unstructured":"Chun J, Kihara Y, Jonnalagadda D, Blaho VA (2019) Fingolimod: lessons learned and new opportunities for treating multiple sclerosis and other disorders. Annu Rev Pharmacol Toxicol 59:149\u2013170","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"8","key":"7963_CR24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2165\/11207350-000000000-00000","volume":"25","author":"LJ Scott","year":"2011","unstructured":"Scott LJ (2011) Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis. CNS Drugs 25(8):673\u2013698","journal-title":"CNS Drugs"},{"issue":"8","key":"7963_CR25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow MK (2023) Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis 82(8):999\u20131014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7963_CR26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM197907053010102","volume":"301","author":"JJ Hooks","year":"1979","unstructured":"Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301(1):5\u20138","journal-title":"N Engl J Med"},{"issue":"4544","key":"7963_CR27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1126\/science.6176024","volume":"216","author":"OT Preble","year":"1982","unstructured":"Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J (1982) Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 216(4544):429\u2013431","journal-title":"Science"},{"issue":"6","key":"7963_CR28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cell.2019.01.016","volume":"176","author":"J Dai","year":"2019","unstructured":"Dai J, Huang YJ, He X, Zhao M, Wang X, Liu ZS, Xue W, Cai H, Zhan XY, Huang SY et al (2019) Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity. Cell 176(6):1447-1460.e1414","journal-title":"Cell"},{"key":"7963_CR29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fphar.2020.00088","volume":"11","author":"J Lai","year":"2020","unstructured":"Lai J, Luo X, Tian S, Zhang X, Huang S, Wang H, Li Q, Cai S, Chen Q (2020) Compound c reducing interferon expression by inhibiting cGAMP accumulation. Front Pharmacol 11:88","journal-title":"Front Pharmacol"},{"issue":"3","key":"7963_CR30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108297","volume":"33","author":"M Tian","year":"2020","unstructured":"Tian M, Liu W, Zhang Q, Huang Y, Li W, Wang W, Zhao P, Huang S, Song Y, Shereen MA et al (2020) MYSM1 represses innate immunity and autoimmunity through suppressing the cGAS-STING pathway. Cell Rep 33(3):108297","journal-title":"Cell Rep"},{"issue":"6121","key":"7963_CR31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ (2013) Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339(6121):786\u2013791","journal-title":"Science"},{"issue":"6121","key":"7963_CR32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ (2013) Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339(6121):826\u2013830","journal-title":"Science"},{"issue":"7748","key":"7963_CR33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","volume":"567","author":"C Zhang","year":"2019","unstructured":"Zhang C, Shang G, Gui X, Zhang X, Bai XC, Chen ZJ (2019) Structural basis of STING binding with and phosphorylation by TBK1. Nature 567(7748):394\u2013398","journal-title":"Nature"},{"issue":"2","key":"7963_CR34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12016-020-08798-2","volume":"59","author":"J Jiang","year":"2020","unstructured":"Jiang J, Zhao M, Chang C, Wu H, Lu Q (2020) Type I interferons in the pathogenesis and treatment of autoimmune diseases. Clin Rev Allergy Immunol 59(2):248\u2013272","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6227","key":"7963_CR35","volume":"347","author":"S Liu","year":"2015","unstructured":"Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu YT, Grishin NV et al (2015) Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347(6227):aaa2630","journal-title":"Science"},{"issue":"12","key":"7963_CR36","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/art.40576","volume":"70","author":"J Wang","year":"2018","unstructured":"Wang J, Dai M, Cui Y, Hou G, Deng J, Gao X, Liao Z, Liu Y, Meng Y, Wu L et al (2018) Association of abnormal elevations in IFIT3 with overactive cyclic GMP-AMP synthase\/stimulator of interferon genes signaling in human systemic lupus erythematosus monocytes. Arthritis Rheumatol 70(12):2036\u20132045","journal-title":"Arthritis Rheumatol"},{"issue":"37","key":"7963_CR37","doi-asserted-by":"crossref","first-page":"32064","DOI":"10.1074\/jbc.M111.238030","volume":"286","author":"A Dobierzewska","year":"2011","unstructured":"Dobierzewska A, Giltiay NV, Sabapathi S, Karakashian AA, Nikolova-Karakashian MN (2011) Protein phosphatase 2A and neutral sphingomyelinase 2 regulate IRAK-1 protein ubiquitination and degradation in response to interleukin-1beta. J Biol Chem 286(37):32064\u201332073","journal-title":"J Biol Chem"},{"issue":"4","key":"7963_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molcel.2006.10.015","volume":"24","author":"S Li","year":"2006","unstructured":"Li S, Wang L, Berman MA, Zhang Y, Dorf ME (2006) RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol Cell 24(4):497\u2013509","journal-title":"Mol Cell"},{"issue":"51","key":"7963_CR39","doi-asserted-by":"crossref","first-page":"47828","DOI":"10.1074\/jbc.M106103200","volume":"276","author":"J Yang","year":"2001","unstructured":"Yang J, Fan GH, Wadzinski BE, Sakurai H, Richmond A (2001) Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J Biol Chem 276(51):47828\u201347833","journal-title":"J Biol Chem"},{"issue":"7","key":"7963_CR40","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCRESAHA.107.168153","volume":"102","author":"W Min","year":"2008","unstructured":"Min W, Lin Y, Tang S, Yu L, Zhang H, Wan T, Luhn T, Fu H, Chen H (2008) AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation. Circ Res 102(7):840\u2013848","journal-title":"Circ Res"},{"issue":"5","key":"7963_CR41","doi-asserted-by":"crossref","first-page":"L849","DOI":"10.1152\/ajplung.90516.2008","volume":"296","author":"TT Cornell","year":"2009","unstructured":"Cornell TT, Hinkovska-Galcheva V, Sun L, Cai Q, Hershenson MB, Vanway S, Shanley TP (2009) Ceramide-dependent PP2A regulation of TNFalpha-induced IL-8 production in respiratory epithelial cells. Am J Physiol Lung Cell Mol Physiol 296(5):L849-856","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"7963_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/v11100948","author":"J Xu","year":"2019","unstructured":"Xu J, Zhang L, Xu Y, Zhang H, Gao J, Wang Q, Tian Z, Xuan L, Chen H, Wang Y (2019) PP2a facilitates porcine reproductive and respiratory syndrome virus replication by deactivating irf3 and limiting type I interferon production. Viruses, 11(10)\uff1a948","journal-title":"Viruses"},{"key":"7963_CR43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbi.2018.03.009","volume":"70","author":"D Shi","year":"2018","unstructured":"Shi D, Tian T, Yao S, Cao K, Zhu X, Zhang M, Wen S, Li L, Shi M, Zhou H (2018) FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus. Brain Behav Immun 70:293\u2013304","journal-title":"Brain Behav Immun"},{"issue":"1","key":"7963_CR44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085000","volume":"9","author":"K Kotlo","year":"2014","unstructured":"Kotlo K, Xing Y, Lather S, Grillon JM, Johnson K, Skidgel RA, Solaro RJ, Danziger RS (2014) PR65A phosphorylation regulates PP2A complex signaling. PLoS ONE 9(1):e85000","journal-title":"PLoS ONE"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07963-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07963-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07963-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:53:30Z","timestamp":1771581210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07963-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7963"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07963-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the Hospital Ethics Review Committee (ethics reference\u00a0numbers: 2023KY-440).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript is approved by all authors for publication.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}